Federal Patent Court of Switzerland [2024]: Mepha Pharma AG v Bristol-Myers Squibb Holdings Ireland Unlimited Company, O2022_007,
Suisse
Retour Ce jugement fait partie de la (des) collection(s) suivante(s): 2024 WIPO Intellectual Property Judges ForumDate du jugement5 mars 2024JuridicitonTribunal fédéral des brevetsDegrés de juridictionPremière instanceType de procédureJudiciaire (civil)SujetBrevets (Inventions), Mise en application des droitsPlaignant/RequérantMepha Pharma AGDéfendeurBristol-Myers Squibb Holdings Ireland Unlimited CompanyMots clés
International competence to assess whether a party is entitled to claim priority,
Significance of parallel proceedings,
Interrelation between EPC and national procedural law
Jugement/DécisionAnglaisFederal Patent Court of Switzerland [2024]: Mepha Pharma AG v Bristol-Myers Squibb Holdings Ireland Unlimited Company, O2022_007 HTMLDocuments supplémentairesAnglais2024 WIPO IP Judges Forum Informal Case Summary – Federal Patent Court of Switzerland [2024]: Mepha Pharma AG v Bristol-Myers Squibb Holdings Ireland Unlimited Company, O2022_007 HTMLLégislation pertinente